Brief: Neoleukin Therapeutics Announces Appointment Of Donna Cochener As General Counsel
15/03/2022 12:17
March 15 (Reuters) - Neoleukin Therapeutics Inc NLTX.O :
* NEOLEUKIN THERAPEUTICS ANNOUNCES APPOINTMENT OF DONNA
COCHENER
AS GENERAL COUNSEL
Source text for Eikon: ID:nGNX1rZNZY
Further company coverage: NLTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurogene
See all newsBrief: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Neurogene Inc reports results for the quarter ended June 30 - Earnings Summary
Neurogene Q2 adjusted loss per share misses estimates on employee costs
Neurogene Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kroger, Meta, Sable